WAG News 66.75 Walgreen Company (WAG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Walgreen Company (WAG) 66.75 $WAG

1 Strategy That May Allow Walgreen to Surpass CVS and Crush Rite Aid
Daniel Jones, The Motley Fool - Motley Fool - Sat Apr 19, 9:00AM CDT
Source: Wikimedia Commons On April 14, news broke that a group of investors who control about 5% of Walgreen 's shares met in Paris last Friday to discuss the benefits of the business engaging in a tax inversion. By doing this type of...

Rite Aid Is on the Right Track
Daniel James, The Motley Fool - Motley Fool - Fri Apr 18, 3:00PM CDT
For years, Rite Aid , America's third-largest drugstore chain, has been locked in a struggle for survival as larger rivals Walgreen and CVS Caremark aggressively expanded their footprints. In fact, Rite Aid posted a loss in every year between...

Walgreens Ranked 60th on 2014 InformationWeek Elite 100 List
Business Wire - Fri Apr 18, 8:19AM CDT
Walgreens (NYSE: WAG) (NASDAQ: WAG) ranked 60th on the 2014 InformationWeek Elite 100, a list of the top business technology innovators in the United States. Walgreens received the recognition for the development and launch of its Balance(R) Rewards loyalty program, which has grown to nearly 80 million active members.

3 Reasons Rite Aid Continues to Crush the Market
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 17, 5:30PM CDT
It's rare for struggling retailers to come back from the brink, but that's exactly what has happened at Rite Aid . Shares in the east and west coast pharmacy operator traded below $1 as mounting losses threatened its survival just a few years ago....

Will Walgreens Relocate to Europe? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 2:20PM CDT
Walgreens has been pressurized by an influential group of its investors to relocate itself to Europe.

The Zacks Analyst Blog Highlights: Intel, Yahoo, Rite Aid, Walgreen and CVS Caremark
PR Newswire - Wed Apr 16, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Intel (Nasdaq:INTC-Free Report), Yahoo (Nasdaq:YHOO-Free Report), Rite Aid Corporation (NYSE:RAD-Free Report), Walgreen Co. (NYSE:WAG-Free Report) andCVS Caremark Corp. (NYSE:CVS-Free Report).

Jim Cramer's 'Mad Money' Recap: Fear and Loathing on Wall Street
at The Street - Tue Apr 15, 7:08PM CDT
That's what professional money managers are feeling as they try and make sense of the today's market action, Cramer says.

Earnings Roundup: Rite Aid Impresses
Todd Campbell, The Motley Fool - Motley Fool - Tue Apr 15, 5:00PM CDT
Rite Aid has been an investment darling over the past year as it continues to boost its profitability and play catch-up to competitors CVS Corp. and Walgreen . Shares in Rite Aid have more than doubled since last fall thanks to an aggressive...

Rite Aid Upped to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 4:35PM CDT
Rite Aid has been witnessing rising earnings estimates on the back of better-than-expected fourth-quarter fiscal 2014 results and it provided an impressive guidance for fiscal 2015.

Walgreen Investor Pressure Is Absurd
Michael Lewis, The Motley Fool - Motley Fool - Tue Apr 15, 3:34PM CDT
Big U.S. corporations shuffling their businesses around the world for tax advantages is nothing new or uncommon. With one of the chunkiest corporate tax rates in the Western world, the United States is a pricey place to call home. For a long-held...

Is Dollar General Worth Your Dollars?
Zahid Waheed, The Motley Fool - Motley Fool - Tue Apr 15, 9:00AM CDT
Dollar General  is among the few retailers which were able to post strong results during this season. Let's see how the company has been able to achieve these results and how it's performing in relation to its peers  Big Lots and Dollar Tree...

Facebook Rumored to be Preparing a Mobile Payment Service; Walgreen Being Pushed to Relocate for Tax Benefits
ACCESSWIRE - Mon Apr 14, 11:39PM CDT
NQ Mobile Inc. (NYSE: NQ) - For an in-depth report on NQ Mobile Inc. follow www.BullTrends.com/stockquote/NQ

Facebook, Walgreen Climb Monday On International News
at Investor's Business Daily - Mon Apr 14, 4:32PM CDT
Overseas news helped boost two U.S. industry leaders Monday, with Walgreen (WAG) gaining 3% and Facebook (FB) up 2%. Facebook is reportedly within weeks of potential permission from Ireland's central bank that would authorize it to add financial...

No Way to Deny the Rite Aid Corporation Turnaround Now
Adam Levine-Weinberg, The Motley Fool - Motley Fool - Mon Apr 14, 3:00PM CDT
As my frequent readers know, I've been a big skeptic about Rite Aid Corporation for the past couple of years. Rite Aid does not have a strong historical track record of profitability, and it comes in a distant third to Walgreen   and CVS...

Wal-Mart, Walgreen, and Conn's Use 3 Strategies to Grow Sales
Celan Bryant, The Motley Fool - Motley Fool - Mon Apr 14, 9:48AM CDT
Walgreen Company (NYSE: WAG) recently announced same-store sales of 3.5% in March. The company credits higher pharmacy sales for the success. In fact, same-store sales rose 8% in the pharmacy section at Walgreen and accounted for 65% of the...

Why Walgreen (WAG) Stock Is Up Today
at The Street - Mon Apr 14, 9:23AM CDT
Shares of Walgreen (WAG) are higher as the retail drugstore chain is pressured by a group of shareholders to consider relocating to Europe to gain tax benefits.

Walgreen (WAG) Crosses Pivot Point Resistance at $65.15
Comtex SmarTrend(R) - Mon Apr 14, 9:01AM CDT
Shares of Walgreen (NYSE:WAG) opened today above their pivot of $63.97 and have already reached the first level of resistance at $65.15. Should the shares continue to rise, the resistance pivots of $66.03 and $68.09 will be of interest.

How Much Is Rite Aid’s Stock Worth?
Brian Nichols, The Motley Fool - Motley Fool - Mon Apr 14, 9:00AM CDT
Rite Aid soared to 13-year highs after it reported fourth-quarter earnings that exceeded expectations and issued bullish guidance for the upcoming year. As a result, Rite Aid's stock price has now risen by almost 500% since 2012. While considering...

Critical Alerts For Walt Disney, Walgreen, BioMarin Pharmaceuticals, Canadian Solar, and MannKind Released By InvestorsObserver
PR Newswire - Mon Apr 14, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for DIS, WAG, BMRN, CSIQ, and MNKD.

This Is the Toughest Part of Investing
Chuck Saletta, The Motley Fool - Motley Fool - Mon Apr 14, 8:14AM CDT
This past week was a tough one for the overall market and the real-money Inflation-Protected Income Growth portfolio . The iPIG portfolio lost more than $1,150 in market price since last week's update , as the S&P 500 dropped about 2.6% in that...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Sandler Partners Unveils 2025 Superstar Trip Destination

Updated Category News Views 179

Sandler Partners Unveils 2025 Superstar Trip Destination Sandler Partners is thrilled to reveal the highly anticipated location for its 2025 Superstar Trip, a special reward designed to honor Partners who have excelled in achieving their growth objectives for the year. The trip will take place at the stunning Susurros del Corazón Resort, located along the picturesque...

Continue Reading
e.l.f. Beauty Stock Insights: Understanding Market Trends Today

Updated Category News Views 309

Market Sentiment Surrounding e.l.f. Beauty Investors with substantial capital are showing a cautious approach towards e.l.f. Beauty (NYSE: ELF). This sentiment isn't just noise in the market; it reflects deeper strategies that should be on the radar of traders and analysts alike. There has been significant insight gleaned from public options activity which suggests that...

Continue Reading
Empowering Teens Through Free AI Bootcamp by Mark Cuban

Updated Category News Views 216

Empowering Teens Through Innovative AI Bootcamp Time is of the essence for high school students eager to launch their careers in technology with the Mark Cuban Foundation's Artificial Intelligence (AI) Bootcamp. Hosted by Girls Inc., this remarkable initiative opens doors for teens interested in the cutting-edge realm of AI. Applications for participation are set to close...

Continue Reading
BlackRock's Major Acquisition of Global Infrastructure Partners

Updated Category News Views 275

BlackRock Secures $12.5 Billion Deal The U.S. Federal Energy Regulatory Commission has recently approved BlackRock's substantial acquisition of Global Infrastructure Partners, valued at $12.5 billion. This approval is a pivotal moment for BlackRock as it seeks to broaden its reach within the infrastructure investment sector. Details of the Acquisition In this significant...

Continue Reading
Key Analyst Initiations Impacting Major Stocks This Week

Updated Category News Views 120

Recent Analyst Initiations: An Overview In the dynamic realm of stock trading, the insights of analysts can have a major impact on market trends. Recently, Wall Street has made significant adjustments to their ratings for several well-known stocks. Below, we summarize the latest analyst actions that may affect investor decisions this week. Arm Holdings plc (NASDAQ: ARM)...

Continue Reading